Complicated skin and soft tissue infections (cSSTIs) encompass a wide clinical spectrum of common infectious diseases that often require acute treatment and inpatient hospital admission. These are the most severe infections having heterogeneous manifestation and involves deeper soft tissues. 1 Ceftaroline is a new parenteral cephalosporin for the treatment of cSSTIs including those due to methicillin-resistant Staphylococcus aureus (MRSA), and community-acquired pneumonia (CAP). Ceftaroline has broad-spectrum activity against gram-positive and gram-negative bacteria And its efficacy and safety have been proven in the specific patient population.
2 To shed more light on the topic, Pfizer and Docplexus have organized an interactive LIVE webinar on 28 th April 2021, from 6.30 PM onwards. Please join experts; Prof. Christian Eckmann, and Dr. Anusha Rohit who will be sharing insights on…
